胆通过GNMT调节肝细胞减弱了NEFA诱导的肝肥胖症
Xueer Du1, Lamei Wang1, Yanfei Dai1
1College of Animal Science and Technology, Northwest A&F University, Yangling, 712100, China.
Stress biology
|November 13, 2025
概括
胆补充剂通过增强甘氨酸N-甲基转移酶 (GNMT) 表达来对抗脂肪肝疾病. 这种机制有助于调节脂质和胆酸代谢,保护肝细胞免受损伤.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 营养生物化学 营养生物化学
- 分子代谢的分子代谢.
背景情况:
- 肝硬化是负能量平衡的一个标志.
- 胆对于脂质代谢是必不可少的,但其在能量缺乏下肝硬化症中的确切作用尚不清楚.
研究的目的:
- 在负能量平衡期间研究胆调节肝脂代谢的分子机制.
- 确定关键的分子标,参与胆对非化脂肪酸 (NEFA) 诱导的肝硬化症的保护作用.
主要方法:
- 已建立的NEFA诱导的肝肥胖症模型使用小牛和人类肝细胞.
- 进行了转录基因分析,以确定差异表达的基因.
- 利用基因淘汰和药理抑制 (AMPK) 来阐明信号通路.
- 量化基因和蛋白质表达水平,并评估细胞甘油三积累和细胞毒性.
主要成果:
- 胆补充剂显著降低了胆固醇积累和胆固醇肝细胞中细胞毒性.
- 甘氨酸N-甲基转移酶 (GNMT) 被确定为一种关键的胆上调基因,对脂质合成,脂肪酸氧化和脂蛋白组合产生中介作用.
- AMP激活蛋白激酶 (AMPK) /Myc/GNMT信号轴与胆的调节机制有关.
- 胆的保护作用取决于GNMT的表达.
结论:
- 胆通过GNMT调节脂质和胆酸代谢来缓解NEFA诱导的肝硬化和损伤.
- AMPK/Myc/GNMT信号通路对于胆的肝脏保护作用至关重要.
- 在乳牛和其他物种中,GNMT代表了管理代谢障碍的潜在治疗目标.
相关概念视频
Indirect-Acting Cholinergic Agonists: Mechanism of Action
2.5K
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
2.5K
Cholinergic Neurons: Neurotransmission
5.0K
Cholinergic neurotransmission involves the synthesis and the release of acetylcholine (ACh) in order to transmit nerve impulses across the synapse. The process begins with the synthesis of acetyl CoA, a precursor for ACh, from ATP, acetate, and coenzyme A in the mitochondria. Choline, another vital precursor, is transported inside the neuron through choline transporters, including high-affinity choline transporter CHT1, low-affinity choline transporter CTL1, and lower-affinity choline...
5.0K
Direct-Acting Cholinergic Agonists: Pharmacokinetics
1.8K
Direct-acting cholinergic agonists, such as synthetic choline esters and naturally occurring alkaloids, exert their effects by enhancing the actions of acetylcholine and stimulating the parasympathetic nervous system. Synthetic choline esters share structural similarities with acetylcholine. For example, they have a positively charged quaternary ammonium or onium group, contributing to their hydrophilic characteristics. As a result, they are poorly absorbed in the body through oral...
1.8K
Synthesis of Phosphatidylcholine in the ER Membrane
4.0K
The ER synthesizes lipids for building cell membranes and performing cellular functions such as energy storage and signaling. The lipid synthesis machinery embedded in the ER membrane primarily collects all reactants from the cytosol. Following synthesis, the secretory pathway and the ER contact sites distribute these lipids to other cellular organelles. Additionally, the energy-rich triacylglycerides are transported from the ER via lipid droplets.
The major components of all eukaryotic cell...
The major components of all eukaryotic cell...
4.0K
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
1.4K
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
1.4K
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
2.0K
Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...
The direct-acting...
2.0K


